NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
NP202 is an experimental drug being developed by Armaron Bio Pty Ltd for potential use as a treatment for people after they have had a heart attack (MI).
Epistemonikos ID: 822afc59583565c1061b30b2e4f94f3ba2f9d4da
First added on: May 12, 2024